Safety Assessment of Triethanolamine and Triethanolamine-Containing Ingredients as Used in Cosmetics

International Journal of Toxicology

Volumn 32, Issue , 2013, Pages 59S-83S

  Fiume, Monice M ^a   Heldreth, Bart ^a   Bergfeld, Wilma F ^a   Belsito, Donald V ^a   Hill, Ronald A ^a   Klaassen, Curtis D ^a   Liebler, Daniel ^a   Marks, James G ^a   Shank, Ronald C ^a   Slaga, Thomas J ^a   Snyder, Paul W ^a   Andersen, F Alan ^a  

^a Scientific Analyst/Writer ^*  (United States)

Author keywords

triethanolamine

Indexed keywords

COSMETIC; ETHANOLAMINE DERIVATIVE; TRIETHANOLAMINE;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PRODUCT SAFETY; REVIEW; TOXICITY TESTING; TOXICITY;

TRIETHANOLAMINE;

ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; ETHANOLAMINES; HUMANS; MOLECULAR STRUCTURE; TOXICITY TESTS;

EID: 84891602470     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581813488804     Document Type: Article

References (87)

1. Elder RE. Final report on the safety assessment of triethanolamine, diethanolamine, and monoethanolamine. J Am Coll Toxicol. 1983; 2(7):183–235.
2. Ikeda K, Migliorese KG. Analysis of nitrosamines in cosmetics. J Soc Cosmet Chem. 1990; 41: 283–333.
3. Mirvish SS. Kinetics of dimethylamine nitrosation in relation to nitrosamine carcinogenesis. J Nat Canc Inst. 1970; 44(633):639.
4. Mirvish SS. Formation of N-nitroso compounds—chemistry, kinetics, and in vivo occurrence. Toxicol Appl Pharmacol. 1975; 31(3):325–351.
5. Turney TA, Wright GA. Nitrous acid and nitrosation. Chem Rev. 1959; 59(3):497–513.
6. Ridd JH. Nitrosation, diazotization, and deamination. Q Rev Chem Soc. 1961; 15: 418.
7. Dow Chemical Company. The Alkanolamines Handbook. Midland, MI: The Dow Chemical Company; 1988. Secondary reference in Knaak et al. 1997.
8. Zhu S, Heppenstall-Butler M, Butler MF, Pudney PDA, Ferdinando D, Mutch KJ. Acid soap and phase behavior of stearic acid and triethanolamine stearate. J Phys Chem B. 2005; 109(23):11753–11761.
9. Organisation for Economic Co-operation and Development. SIDS Dossier on Chem ID: 139-96-6 (TEA-lauryl sulfate); 2011. http://webnet.oecd.org/hpv/ui/Publications.aspx.
10. Zhu S, Pudney PDA, Heppenstall-Butler M, Butler MF, Ferdinando D, Kirkland M. Interaction of the acid soap of triethanolamine stearate and stearic acid with water. J Phys Chem B. 2007; 111(5):1016–1024.
11. Kraeling MEK, Yourick JJ, Bronaugh RL. In vitro human skin penetration of diethanolamine. Food Chem Toxicol. 2004; 42(10):1553–1561.
12. Saghir SA, Brzak A, Markham DA, Bartels MJ, Stott WT. Investigation of the formation of N-nitrosodiethanolamine in B6C3F1 mice following topical administration of triethanolamine. Reg Toxicol Pharmacol. 2005; 43(1):10–18.
13. Gottschalck TE, Bailey JE, eds. International Cosmetic Ingredient Dictionary and Handbook. Washington, DC: Personal Care Products Council; 2010.
14. Food and Drug Administration (FDA). Frequency of use of cosmetic ingredients. In: FDA Database. Washington, DC: FDA; 2011.
15. Personal Care Products Council. Updated concentration of use by FDA product category: TEA-containing ingredients. Unpublished data submitted by the Council on May 17, 2011:3.
16. Personal Care Products Council. Concentration of use by FDA product category: TEA containing ingredients. Unpublished data submitted by the Council on March 15, 2011:3.
17. Organisation for Economic Co-operation and Development. SIDS Initial assessment report for SIAM 3 (triethanolamine); 2010. http://webnet.oecd.org/Hpv/UI/SIDS_Details.aspx?id=CEF02D50-2294-462B-8027-FB4EC67D5D81. Accessed February 16, 1995.
18. Johnsen MA. The influence of particle size. Spray Technol Marketing. 2004;14(11):24-27.
19. Rothe H. Special Aspects of Cosmetic Spray Evalulation.Unpublished data presented at the 26 September CIR Expert Panel meeting, Washington, DC; September 26, 2011.
20. Rothe H, Fautz R, Gerber E, et al. Special aspects of cosmetic spray safety evaluations: principles on inhalation risk assessment. Toxicol Lett. 2011; 205(2):97–104.
21. Bremmer HJ, Prud’homme de Lodder LCH, Engelen JGM. Cosmetics fact sheet: to assess the risks for the consumer. Updated version for Cons Expo 4. Report no. RIVM 320104001/2006; 2006: 1–77.
22. European Commission. European Commission Enterprise and Industry. Cosmetics—cosing. Annex III/1,62—trialkylamines, trialkanolamines and their salts. http://ec.europa.eu/consumers/cosmetics/cosing/index.cfm?fuseaction=search.results. http://ec.europa.eu/enterprise/cosmetics/cosing/. Accessed June 6, 2010.
23. European Commission. Cosing database. Annex V,. List of preservatives allowed in cosmetic products; EC regulation (v.2). http://ec.europa.eu/consumers/cosmetics/cosing/index.cfm?fuseaction=search.results&annex_v2=V&search#. Accessed May 14, 2011
24. Food and Drug Administration. Everything added to food in the united states (EAFUS). http://www.fda.gov/Food/Food Ingredients Packaging/ucm115326.htm. Accessed June 8, 2010
25. Lessmann H, Uter W, Schnuch A, Geier J., Skin sensitizing properties of ethanolamines mono-, di-, and triethanolamine. Data analysis of a multicentre surveillance network (IVDK) and review of literature. Contact Derm. 2009;60(5):243–255
26. Kraeling MEK, Bronaugh RL., In vitro absoprtion of triethanolamine through human skin. Cutan Ocul Toxicol. 2003;22(3):137–145
27. Stott WT, Waechter JM, Rick DL, Mendrala AL,. Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice. Food Chem Toxicol. 2000;38(11):1043–1051
28. National Toxicology Program. NTP Technical report on the toxicology and carcinogenesis studies of triethanolamine (CAS no. 102-71-6) in B6C3F1 mice (dermal study). NTP TR 518; 2004. http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr518.pdf
29. Kohri N, Matsuda T, Umeniwa K, Miyazaki K, Arita T,. Development of assay method in biological fluids and biological fate of triethanolamine. Yakuzaigaku. 1982;42(4):342–348
30. Kao Company. Acute oral toxicity test in rats. Fixed dose method (Unpublished report no. CD-95/4286T). Unpublished data cited in the SIDS Dossier on Chem ID: 139-96-6 (TEA-lauryl sulfate); 2008
31. Melnick R, Hejtmancki M, Mezza L, Ryan M, Persing R, Peters A,. Comparative effects of triethanolamine (TEA) and diethanolamine (DEA) in short-term dermal studies. (Secondary reference in Melnick and Tomaszewski 1990). The Toxiologist. 1988;8:127
32. DePass LR, Fowler EH, Leung HW,. Subchronic dermal toxicity study of triethanolamine in C3H/HeJ mice. Food Chem Toxicol. 1995;33(8):675–680
33. National Toxicology Program. Toxicology and carcinogenesis studies of triethanolamine (CAS no. 102-71-6) in F344/N rats and B6C3F1 mice (dermal studies). TR no. 449; 1999
34. Hejtmancik M, Mezza L, Peters AC, Athey PM., The Repeated Dose Dosed Water Study of Triethanolamine (CAS No. 102-71-6) in Fischer-344 Rats. Columbus, OH: Columbus Division Laboratories; 1985. Unpublished data summarized in Knaak et al. 1997
35. Hejtmancik M, Mezza L, Peters A, Athey PM., The Repeated Dose Dosed Water Study of Triethanolamine (CAS No. 102-71-6) in B6C3F1 Mice. Columbus, OH: Columbus Division Laboratories; 1985. Unpublished data summarized in Knaak et al. 1997
36. Gamer AO, Rossbacher R, Kaufmann W, van Ravenzwaay B,. The inhalation toxicity of di- and triethanolamine upon repeated exposure. Food Chem Toxicol. 2008;46:2173–2183
37. Mosberg A, McNEill D, Hejtmancik M, Persing RL, Peters A., The Repeated Dsoe Inhalation Study of Triethanolamine (CAS No. 102-71-6) in Fischer-344 Rats. Columbus, OH: Battelle Columbus Division Laboratories; 1985. Unpublished data summarized in Knaak et al. 1997
38. Mosberg A, McNEill D, Hejtmancik M, Persing RL, Peters A., The Repeated Dose Inhalation Study of Triethanolamine (CAS No. 102-71-6) in B6C3F1 Mice. Columbus, OH: Battelle Columbus Division Laboratories; 1985. Unpublished data summarized in Knaak et al. 1997
39. Battelle Columbus Laboratories. Mating trial dermal study of triethanolamine (CAS no. 102-71-6) in Fischer 344 rats. Final report (NIH contract no. N01-ES-45068); 1988. Secondary reference in NTP 2004
40. Battelle Columbus Laboratories. Mating trial dermal study of triethanolamine (CAS no. 102-71-6) in Swiss CD-1 mice. Final report (NIH contract no. N01-ES-45068); 1988. Secondary reference in NTP 2004
41. Environmental Protection Agency. High production volume (HPV) challenge program revised test plan and robust summaries for polyphosphoric acid esters of triethanolamine, sodium salts; 2004
42. Inoue K, Sunakawa T, Okamoto K, Tanaka Y,. Mutagenicity tests and in vitro transformation assays on triethanolamine. Mutat Res. 1982;101(4):305–313
43. Dean BJ, Brooks TM, Hodson-Walker G, Hutson DH,. Genetic toxicology testing of 41 industrial chemicals. Mutat Res. 1985;153(1-2):57–77
44. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E., Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ Mutagen. 1986;8(suppl 7):1–119
45. Galloway SM, Armstrong MJ, Reuben, et al. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluation of 108 chemicals. Environ Mol Mutagen. 1987;10(suppl 10):1–175
46. Witt KL, Knapton A, Wehr CM, et al. Micronucleated erythrocyte frequency in peripheral blood of B6C3F1mice from short-term. Prechronic, and chronic studies of the NTP carcinogenesis bioassay program. Environ Mol Mutagen. 2000;36(3):163–194
47. National Toxicology Program. Toxicology and carcinogenesis studies of triethanolamine (CAS NO. 102-71-6) in B6C3F1 mice (dermal study). NTP TR 518; 2004. Report no. NIH Publication NO 04-4452
48. Tennant RW, French JE, Spalding JW,. Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ Health Perspect. 1995;103(10):942–950
49. Konishi Y, Denda A, Uchida K, et al. Chronic toxicity carcinogenicity studies of triethanolamine in B6C3F1, mice. Fundam Appl Toxicol. 1992;18(1):25–29
50. Maekawa A, Onodera H, Tanigawa H, et al. Lack of carcinogenicity of triethanolamine in F344 rats. J Toxicol Environ Health. 1986;19(3):345–357
51. Ghoshal AK, Farber E,. The induction of liver cancer by dietary deficieny of choline and methionine without added carcinogens. Carcinogenesis. 1984;5(10):1367–1370
52. Rogers AE., Methyl donors in the diet and responses to chemical carcinogens. Am J Clin Nutr. 1995;61(suppl):659S–665S
53. Stott WT, Radtke BJ, Linscombe VA, Mar MH, Zeisel SH., Evaluation of the potential of triethanolamine to alter hepatic choline levels in female B6C3F1 mice. Toxicol Sci. 2004;79(2):242–247
54. International Agency for Research on Cancer. Triethanolamine. IARC Monogr Eval Carcinog Risks Hum. 2000;77:381–401
55. Tornier C, Rosdy M, Maibach HI., In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols. Toxicol In Vitro. 2006;20(4):401–416
56. Anderson SE, Brown KK, Butterworth LF, et al. Evaluation of irritancy and sensitization potential of metalworking fluid mixtures and components. J Immunotoxicol. 2009;6(1):19–29
57. Müller-Decker K, Heinzelmann T, Fürstenberger G, Kecskes A, Lehmann WD, Marks F,. Arachidonic acid metabolism in primary irritant dermatitis produced by patch testing of human skin with surfactants. Toxicol Appl Pharmacol. 1998;153(1):59–67
58. Tavss EA, Eigen E, Kligman AM,. Anionic detergent-induced skin irritation and anionic detergent-induced pH rise of bovine serum albumin. J Soc Cosmet Chem. 1988;39(4):267–272
59. National Toxicology Program. Abstract for IMM90005. The immunotoxicity of triethanolamine (CAS no. 102-71-6). http://ntp.niehs.nih.gov/?objectid=03E847AC-AC78-4065-BE8E52A8BB9CFBA7. Accessed October 14, 2010.
60. Tosti A, Morelli R, Bardazzi F,. Prevalence and sources of sensitization to emulsifiers: a clinical study. Contact Derm. 1990;23(2):68–72
61. Batten TL, Wakeel RA, Douglas WS, et al. Contact dermatitis from the old formula E45 cream. Contact Derm. 1994;30(3):159–161
62. Geier J, Lessmann H, Frosch PJ, et al. Patch testing with components of water-based metalworking fluids. Contact Derm. 2003;49(2):85–90
63. Geier J, Lessmann H, Dickel H, et al. Patch test results with the metalworking fluid series of the German contact dermatitis research group (DKG). Contact Derm. 2004;51(3):118–130
64. Bulich AA, Tung KK, Scheibner G,. The luminescent bacteria toxicity test: its potential as an in vitro alternative. J Biolumin Chemilumin. 1990;5(2):71–77
65. Gordon VC,. Utilization of biomacromolecular in vitro assay systems in the prediction of in vivo toxic responses. Lens Eye Toxic Res. 1992;9(3-4):211–227
66. Jones SK, Kennedy TC,. Contact dermatitis from triethanolamine in E45 cream. Contact Derm. 1988;19(3):230
67. Savonius B, Keskinen H, Tupperainen M, Kanerva L,. Occupational asthma caused by ethanolamines. Allergy. 1994;49(10):877–881
68. Andersen KE, Roed-Petersen J, Kamp P,. Contact allergy related to TEA-PEG-3 cocamide sulfate and cocamidopropyl betaine in a shampoo. Contact Derm. 1984;11(3):192–193
69. Andersen FA,ed. Final report on the safety assessment of glycolic acid, ammonium, calcium, potassium, and sodium glycolates, methyl, ethyl, propyl, and butyl glycolates, and lactic acid, ammonium, calcium, potassium, sodium, and TEA-lactates, methyl, ethyl, isoprpyl, and butyl lactates, and lauryl, myristyl, and cetyl lactates. Int J Toxicol. 1998; 17(suppl 1):1–241.
70. Elder RE ed. Final report on the safety assessment of TEA-Lauryl Sulfate. J Am Coll Toxicol. 1982; 1(4):143–167.
71. Andersen FA ed. Final report on the safety assessment of TEA stearate. J Am Coll Toxicol. 1995; 14(3):240–248.
72. Fiume MM, Heldreth BA, Bergfeld WF, et al. Safety assessment of alkyl PEG ethers as used in cosmetics. Int J Toxicol. 2012; 31(suppl 2):169S–244S.
73. Elder RL. Final report on the safety assessment of sodium lauryl sulfate and ammonium lauryl sulfate. J Am Coll Toxicol. 1983; 2(7):127–181.
74. Burnett CL, Bergfeld W, Belsito DV, et al. Final report on the safety assessment of Cocos nucifera (coconut) oil and related ingredients. Int J Toxicol. 2011; 30(suppl 1):5S–16S.
75. Elder RL ed. Final report on the safety assessment of isostearic acid. J Am Coll Toxicol. 1983; 2(7):61–74.
76. Elder RL ed. Final report on the safety assessment of oleic acid, lauric acid, palmitic acid, myristic acid, and stearic acid. J Am Coll Toxicol. 1987; 6(3):321–401.
77. Becker LC, Bergfeld WF, Belsito DV, et al. Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics. Int J Toxicol. 2010; 29(3):162S–186S.
78. Burnett CL, Fiume MM, Bergfeld WF, et al. Final report of the CIR expert panel on the safety of plant-derived fatty acid oils and used in cosmetics. Washington, DC: CIR; 2011. http://cir-safety.org.
79. Fiume MM, Bergfeld WF, Belsito DV, et al. Final report on the safety assessment of sodium cetearyl sulfate and related alkyl sulfates as used in cosmetics. Int J Toxicol. 2010; 29(suppl 2):115S–132S.
80. Robinson VC, Bergfeld WF, Belsito DV, et al. Final report of the amended safety assessment of sodium laureth sulfate and related salts of sulfated ethoxylated alcohols. Int J Toxicol. 2010; 29(Suppl 3):151S–161S.
81. Elder RL ed. Final report on the safety assessment of sodium laureth sulfate and ammonium laureth sulfate. J Am Coll Toxicol. 1983; 2(5):1–34.
82. Elder RE, ed. Final report on the safety assessment of sorbic acid and potassium sorbate. J Am Coll Toxicol. 1988; 7(6):837–880.
83. Robinson VC, Bergfeld WF, Belsito DV, et al. Amended safety assessment of tall oil acid, sodium tallate, potasstium tallate, and ammonium tallate. Int J Toxicol. 2009; 28(suppl 3):252S–258S.
84. Melnick RL, Tomaszewski KE. Triethanolamine. In: Buhler DR, ed. Ethel Browning’s Toxicity and Metabolism of Industrial Solvents. Vol. II. Nitrogen and Phosphorus Solvents. 2nd ed. Amsterdam/New York/Oxford: Elsevier; 1990: 41–50.
85. Rohmann C, Wischniewski T. Sulfur-containing esters of morpholinoethanol and thiomorpholinoethanol. Arch Pharm. 1959; 292: 797–792.
86. Yuan XL, Jiang S, Mei X. Hydroxyl ammonium ionic liquids: synthesis, properties, and solubility of SO2. J Chem Eng Data. 2007; 52(2):596–599.
87. Personal Care Products Council. Updated concentration of use of triethanolamine. Unpublished data submitted by the Council November 8, 2010:3.